Hiroshi Iesato
Hiroshi Iesato publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Oncology, on topics such as Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment and Metastasis and carcinoma case studies.
- World rank
- #7,528,944 of 7,710,434 ranked researchers
- Rank in Japan
- #361,321 of 383,136
- Works
- 42
- Citations
- 90
- Citations per work
- 2.1
What does Hiroshi Iesato research?
Hiroshi Iesato's work is mostly in Medicine (79%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3379.2%
- Medicine3379.2%
- Everything else920.8%
- 1Pulmonary and Respiratory Medicine26% of their works
- 2Surgery22% of their works
- 3Oncology13% of their works
- 4Epidemiology8% of their works
- 5Gastroenterology7% of their works
- 6Infectious Diseases4% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Metastasis and carcinoma case studies
- Neuroendocrine Tumor Research Advances
- Multiple and Secondary Primary Cancers
- Neuroblastoma Research and Treatments
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
Which keywords describe Hiroshi Iesato's research?
The keywords of their largest research topics: Chemotherapy, Survival Analysis, Endoscopic Resection, Gastric Cancer, Genetic Mutations, Imatinib Mesylate, Immunotherapy and Lung Tumors.
- Surgical Complications
- Pancreatic Cancer
- Multiple Primary Cancers
- Cetuximab
- Pancreatic Neuroendocrine Tumors
- Sunitinib
- Lung Tumors
- Imatinib Mesylate
- Gastric Cancer
- Survival Analysis
- Chemotherapy
- Endoscopic Resection
- Genetic Mutations
- Immunotherapy
- Metastatic Carcinomas
- Neuroendocrine Tumors
- ALK
- KRAS Mutations
- Neuroblastoma
- Second Primary Neoplasms
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy203 topics
- Survival Analysis192 topics
- Endoscopic Resection141 topic
- Gastric Cancer141 topic
- Genetic Mutations82 topics
- Imatinib Mesylate61 topic
- Immunotherapy62 topics
- Lung Tumors61 topic
- Metastatic Carcinomas61 topic
- Sunitinib61 topic
- Neuroendocrine Tumors51 topic
- Pancreatic Neuroendocrine Tumors51 topic
- ALK31 topic
- Cetuximab31 topic
- KRAS Mutations31 topic
- Multiple Primary Cancers31 topic
- Neuroblastoma31 topic
- Pancreatic Cancer31 topic
- Second Primary Neoplasms31 topic
- Surgical Complications31 topic
Where does Hiroshi Iesato work?
Hiroshi Iesato's main affiliation in the publication record is Oji General Hospital, Japan.
How many publications and citations does Hiroshi Iesato have?
OpenAlex counts 42 works and 90 citations for Hiroshi Iesato, an h-index of 6, ranking #7,528,944 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hiroshi Iesato. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.